
Europe Medical Aesthetics Market
No. of Pages: 130 | Report Code: TIPRE00025333 | Category: Life Sciences
No. of Pages: 130 | Report Code: TIPRE00025333 | Category: Life Sciences
The European medical aesthetics market is divided into Germany, the UK, France, Italy, Spain, and the rest of Europe. Europe occupies a significant position in the global medical aesthetic market and is expected to register a robust growth rate during the forecast period. Countries such as Germany and Italy are expected to be the largest contributor to market growth in the region, whereas countries such as France, the UK, and Spain are expected to have growth opportunities for the medical aesthetic market due to the rising number of aesthetic procedures among the younger population. Also, the developments in the medical devices industry and rising numbers of aesthetic clinics may offer vital growth opportunities for market growth. The market for medical aesthetics market is estimated to be the fastest-growing market owing to the rising numbers of skin aesthetic procedures. According to the ISAPS, in 2018, about 311,456 surgical procedures were performed, and 542,752 non-surgical procedures were performed. The total aesthetic procedures performed were 854,208, and Italy ranks 6th in world for performing aesthetic procedures by contributing by 3.7%.
The COVID-19 pandemic has shown a significant negative impact on the global and European health economies. Health services in the region are highly prioritized to serve the COVID-19 patients. The routine health care services have remained suspended. Therefore, it has affected the aesthetic medical services and its dependable revenue generation in the region. Europe has been in an area of dynamic development in the field of plastic surgery, adapting to differing cultures, traditions, and surgical and medical philosophies. In the recent times, these changes have been even more significant and rapid. On the other hand, the spread of the novel coronavirus infection has grown significantly, it has raised question regarding the safety from the aesthetic treatments done by lasers, and micro needling. Thus, the aesthetic services have been totally shutdown in the European countries. These countries have undergone second phase of lockdown as they have experienced second wave of the COVID-19 outbreak. Countries such as the UK, Belgium, Germany, Switzerland, France, Italy, and Spain are highly affected due to the outbreak. Therefore, the lockdown has widely affected the flow of businesses across the region and outside the region. Various conferences related to the aesthetic industry are being conducted through webinars. Hence, it is expected that negative impact on the market is likely to continue in the coming years.
Strategic insights for the Europe Medical Aesthetics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,562.67 Million |
Market Size by 2028 | US$ 3,384.96 Million |
Global CAGR (2021 - 2028) | 11.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Medical Aesthetics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The medical aesthetics market in Europe is expected to grow from US$ 1,562.67 million in 2021 to US$ 3,384.96 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2021 to 2028. Surge in use of dermal fillers and botulinum toxin for enhancing facial aesthetics; over the past two decades, there has been an unprecedented surge in the popularity of elective aesthetic procedures. Moreover, there is an increasing demand for less invasive aesthetic procedures such as dermal fillings and botulinum toxin A (BoNTA). The global statistics of the International Society of Aesthetic Plastic Surgery indicates the rise in the aesthetic applications of BoNTA and dermal filling implants by 7% and 18%, respectively, during 2015–2016. Nonsurgical facial rejuvenation using botulinum toxin and hyaluronic acid has become highly popular in the Middle East and other parts of the world in the last 10 years. The correction of facial rhythm and loss of volume is the basic principle of aesthetic rejuvenation of the face. Botulinum toxin injections are primarily indicated to correct dynamic rhytides, while dermal fillers aim to increase volume and improve static rhytides. Botulinum toxin, a powerful neurotoxin, causes chemodenervation of muscles. Dermal fillers is a non-energy-based procedure that adds volume and fullness to a person's skin. The cost efficiency and increasing aging population are the key factors driving the demand for dermal fillers. Further, surge in demand for superior materials and techniques required for dental aesthetics procedures has spurred research into the same. However, nonsurgical facial aesthetic procedures received less attention from the dental community until chemicals such as hyaluronic acid fillers and botulinum toxin were requested by patients, which led dental manufacturers to add these materials to their catalogs and advertisements. The increasing number of accredited basic and advanced hands-on training courses in the use of such materials has been advertised in most dental journals and journals that are currently available. Facial rejuvenation has become a major issue of psychosocial wellbeing in this era of fashion, beauty, and trends. Thus, the increasing use of dermal fillers and botulinum toxin for enhancing facial aesthetics is fueling the medical aesthetics market growth. This is bolstering the growth of the medical aesthetics market.
Based on product market is segmented into facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, hair removal devices, tattoo removal devices and others. In 2020, the facial aesthetic products segment held the largest share of the market, by product. Based on the application market was segmented into facial and body contouring, facial and skin rejuvenation, breast augmentation, hair removal, reconstructive surgery, tattoo removal and others. In 2020, the facial and body contouring segment held the largest share of the market, by application. Based on the end user market was segmented into hospitals, dermatology clinics, medical spas and beauty centers and home care. In 2020, the hospitals segment held the largest share of the market, by end user.
A few major primary and secondary sources referred to for preparing this report on the medical aesthetics market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc, Alma Lasers, Cutera Inc, El.En. S.p.A, Galderma, Hologic, Inc, Lumenis, and Mentor Worldwide, LLC among others.
The Europe Medical Aesthetics Market is valued at US$ 1,562.67 Million in 2021, it is projected to reach US$ 3,384.96 Million by 2028.
As per our report Europe Medical Aesthetics Market, the market size is valued at US$ 1,562.67 Million in 2021, projecting it to reach US$ 3,384.96 Million by 2028. This translates to a CAGR of approximately 11.7% during the forecast period.
The Europe Medical Aesthetics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Aesthetics Market report:
The Europe Medical Aesthetics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Aesthetics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Aesthetics Market value chain can benefit from the information contained in a comprehensive market report.